Mitsubishi Touts $940M Arbitration Win Over Gilenya Royalties
By Caleb Symons ( February 16, 2023, 9:09 PM EST) -- Mitsubishi Chemical Group Corp. is celebrating an arbitral judgment that the Japanese company said entitles it to approximately $940 million in royalty payments from pharmaceutical giant Novartis over its development of a popular medication used to treat multiple sclerosis....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.